Skip to content

RHHBY history

Every recorded change to RHHBY's data, most recent first.

  1. CurrentNext earnings date moved to Jan 22, 2027; next earnings date is now an estimate; the company overview was rewritten; the investment thesis was rewritten; the listed risks were updated; checkpoint passed: Nine-month sales 2026: growth at constant rates; new checkpoint: FDA decision on giredestrant in advanced breast cancer; checkpoint moved to Jan 22, 2027: Full-year 2026 results and 2027 outlook; recent events were updated.
  2. This company was added.